Thor Medical ASA (LON:0R6Y)

Thor Medical ASA Statistics

Total Valuation

LON:0R6Y has a market cap or net worth of GBP 144.25 million. The enterprise value is 127.64 million.

Market Cap	144.25M
Enterprise Value	127.64M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	354.14M
Shares Outstanding	n/a
Shares Change (YoY)	+17.08%
Shares Change (QoQ)	+30.71%
Owned by Insiders (%)	3.77%
Owned by Institutions (%)	4.78%
Float	119.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19,992.85
PB Ratio	4.22
P/TBV Ratio	10.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.03
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.84

Financial Position

The company has a current ratio of 8.87, with a Debt / Equity ratio of 0.02.

Current Ratio	8.87
Quick Ratio	8.78
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	-323.39

Financial Efficiency

Return on equity (ROE) is -16.06% and return on invested capital (ROIC) is -10.77%.

Return on Equity (ROE)	-16.06%
Return on Assets (ROA)	-9.08%
Return on Invested Capital (ROIC)	-10.77%
Return on Capital Employed (ROCE)	-12.01%
Weighted Average Cost of Capital (WACC)	3.99%
Revenue Per Employee	555
Profits Per Employee	-326,944
Employee Count	13
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-182,542
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +116.00% in the last 52 weeks. The beta is -0.05, so LON:0R6Y's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	+116.00%
50-Day Moving Average	4.80
200-Day Moving Average	3.49
Relative Strength Index (RSI)	65.26
Average Volume (20 Days)	10,092

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0R6Y had revenue of GBP 7,215 and -4.25 million in losses. Loss per share was -0.02.

Revenue	7,215
Gross Profit	7,215
Operating Income	-4.62M
Pretax Income	-4.43M
Net Income	-4.25M
EBITDA	-3.74M
EBIT	-4.62M
Loss Per Share	-0.02

Balance Sheet

The company has 16.19 million in cash and 627,714 in debt, with a net cash position of 15.56 million.

Cash & Cash Equivalents	16.19M
Total Debt	627,714
Net Cash	15.56M
Net Cash Per Share	n/a
Equity (Book Value)	34.16M
Book Value Per Share	0.10
Working Capital	15.90M

Cash Flow

In the last 12 months, operating cash flow was -3.21 million and capital expenditures -2.15 million, giving a free cash flow of -5.35 million.

Operating Cash Flow	-3.21M
Capital Expenditures	-2.15M
Free Cash Flow	-5.35M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-64,031.91%
Pretax Margin	-61,438.88%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0R6Y does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.08%
Shareholder Yield	-17.08%
Earnings Yield	-2.95%
FCF Yield	-3.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0R6Y has an Altman Z-Score of 3.77 and a Piotroski F-Score of 2.

Altman Z-Score	3.77
Piotroski F-Score	2